You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TRDA Sale Disclosure
Mpm Bioventures 2018, L.p. · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$180.69K
Mpm Bioventures 2018, L.p. 10% owner
TRDA
Entrada Therapeutics
TRDA
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
TRDA daily price context
Close on/before transaction
$7.3
Sep 2, 2026
First close after public filing
$7.13
Sep 4, 2026
30-day return after filing
-23.14%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,131 shares @ $7.19
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001231919-26-001144
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$617.38K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Entrada Therapeutics, Inc. TRDA | Sale | Sep 3, 2026 | $231.33K |
| Entrada Therapeutics, Inc. TRDA Current | Sale | Sep 2, 2026 | $180.69K |
| Entrada Therapeutics, Inc. TRDA | Sale | Sep 1, 2026 | $205.36K |